–
MBX Biosciences, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
millions USD
FY22:
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY22 to FY25
millions USD
FY22:
−25.2
FY23:
−35.3
FY24:
−68.2
FY25:
−98.1
(positive)
Change from FY22 to FY25
millions USD
FY22:
−24.7
FY23:
−35.2
FY24:
−68.0
FY25:
−97.8
(positive)
Change from FY22 to FY25
millions USD
FY22:
−26.1
FY23:
−32.6
FY24:
−61.9
FY25:
−87.0
(positive)
Change from FY22 to FY25
millions USD
FY22:
−26.1
FY23:
−32.6
FY24:
−61.9
FY25:
−87.0
All amounts in millions USD FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far.